bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-07 07:01 |
bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de…
|
French | PDF • 262.7 KB | ||
| 2025-04-02 14:13 |
Mars 2025 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | PDF • 106.1 KB | ||
| 2025-03-24 09:30 |
Release of the Universal Registration Document including the Annual Financial R…
|
English | PDF • 103.7 KB | ||
| 2025-03-24 09:28 |
Communiqué de mise à disposition du Document d'Enregistrement Universel incluan…
|
French | PDF • 104.0 KB | ||
| 2025-03-21 11:22 |
Document d'enregistrement universel 2024
|
French | ZIP • 26.1 MB | ||
| 2025-03-18 07:01 |
bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/A…
|
English | PDF • 279.7 KB | ||
| 2025-03-18 07:01 |
bioMérieux obtient l’autorisation 510(k) de la FDA pour VITEK® COMPACT PRO, un …
|
French | PDF • 310.7 KB | ||
| 2025-03-14 08:35 |
AG 2025 - Avis de mise à disposition des documents préparatoires
|
French | PDF • 104.0 KB | ||
| 2025-03-07 07:01 |
bioMérieux – 2024 Financial Results
|
English | PDF • 591.5 KB | ||
| 2025-03-07 07:01 |
bioMérieux – Résultats annuels au 31 décembre 2024
|
French | PDF • 510.7 KB | ||
| 2025-03-04 14:36 |
Février 2025 - Déclaration sur le nombre d'actions composant le capital social …
|
French | PDF • 106.1 KB | ||
| 2025-02-13 07:01 |
bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food…
|
English | PDF • 271.5 KB | ||
| 2025-02-13 07:01 |
bioMérieux lance GENE-UP® TYPER, une solution diagnostique innovante destinée a…
|
French | PDF • 265.6 KB | ||
| 2025-02-11 07:01 |
bioMérieux receives U.S. FDA clearance for the new version of its molecular tes…
|
English | PDF • 277.8 KB | ||
| 2025-02-11 07:01 |
bioMérieux obtient l’autorisation de la FDA américaine pour la nouvelle version…
|
French | PDF • 284.0 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
